Gain Therapeutics, Inc.
GANXReported to SECin USCIK 0001819411Filings at SEC EDGAR
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 6. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| GOLDSTEIN DOV A MD— | Award | nothing paid25,000 shares | Jul 17, 2026 | GOLDSTEIN DOV A MD | nothing paid | Award | 25,000 | Jul 17, 2026 |
| Nicaise Claude— | Award | nothing paid25,000 shares | Jul 17, 2026 | Nicaise Claude | nothing paid | Award | 25,000 | Jul 17, 2026 |
| Islam Khalid— | Award | nothing paid25,000 shares | Jul 17, 2026 | Islam Khalid | nothing paid | Award | 25,000 | Jul 17, 2026 |
| Melincoff Gwen A— | Award | nothing paid25,000 shares | Jul 17, 2026 | Melincoff Gwen A | nothing paid | Award | 25,000 | Jul 17, 2026 |
| Riley Jeffrey Scott— | Award | nothing paid25,000 shares | Jul 17, 2026 | Riley Jeffrey Scott | nothing paid | Award | 25,000 | Jul 17, 2026 |